logo for Tandem Diabetes Care

Tandem Diabetes Care

Manufacturing · California, United States · 2,400 Employees

View Company Info for Free

About

Headquarters

12400 High Bluff Dr, San Diego, California, 921...

Phone Number

(858) 366-6900

Revenue

$770 Million

Stock Symbol

TNDM

Industry

Medical Devices & Equipment Manufacturing

Most Recent Scoops

Oct 21 2024
Hiring Plans
Oct 8 2024
Open Position
See all scoops

Highlights

$884.8M

Total Funding Amount

$250M

Most Recent Funding Amount

13

Number of Funding Rounds

View details

Who is Tandem Diabetes Care

Founded in 2006 and headquartered in San Diego, California, Tandem Diabetes Care is a company that manufactures medical devices that help measure blood sugar in the blood of diabetic patients.Read more
Tandem Diabetes Care's Social MediaPopular SearchesTANDEM DIABETES CARE IncTandem Diabetes CareTandem Diabetes Care - IncTandem RehabilitationAbela Pharmaceuticals IncSIC Code 38,384NAICS Code 33,339Ticker NASDAQ: TNDMShow more

Tandem Diabetes Care Org Chart

PhoneEmail
Leigh Vosseller

Executive Vice President & Chief Financial Of...

PhoneEmail
Susan Morrison

Chief Administrative Officer & Executive Vice...

PhoneEmail

PhoneEmail

Is Tandem Diabetes Care your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Tandem Diabetes Care

Compare insights from companies similar to Tandem Diabetes Care, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Tandem Diabetes Care

$770M
2.4K
Placeholder for Top Executive
$1.9B
3K
Placeholder for Top Executive
$1.1B
2.0K
Placeholder for Top Executive
$1.1B
5K
Placeholder for Top Executive
$658.3M
1.4K
Placeholder for Top Executive
$426.2M
1.7K
Placeholder for Top Executive
Illustration of an envelope

Tandem Diabetes Care financials insights

Gather financial insights about Tandem Diabetes Care, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Tandem Diabetes Care Employee Growth Rate

Graph showing projected employee growth data for Tandem Diabetes Care

View Tandem Diabetes Care’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Tandem Diabetes Care Tech Stack

A closer look at the technologies used by Tandem Diabetes Care

Most Recent Scoops

Oct 21 2024
Hiring Plans
Hiring Plans
Oct 8 2024
Open Position
Oct 8 2024
Open Position
Oct 8 2024
Open Position
Sep 20 2024
Hiring Plans
Tandem Diabetes Care has more open roles in Mobile Development than it has had at any time in the past 12 months.
See more scoops

Tandem Diabetes Care News & Media

  • Tandem Diabetes Care Announces Upcoming Conference Presentations

    SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: 36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3, 2024 at 8:00am Eastern Time (5:00am Pacific Time), and Citi’s 2024 Global Healthcare Conference on Wednesday, December 4, 2024 at 1:00pm Eastern Time (10:00am Pacific Time). The presentations wil
  • Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance

    SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2024 and increased sales guidance for the year ending December 31, 2024. Third Quarter 2024 Highlights Worldwide GAAP sales increased 31 percent to $244.0 million compared to third quarter 2023; worldwide non-GAAP sales(1) increased 25 percent to $242.9 million compared to third quarter 2023. Gr
  • Tandem Diabetes Care Announces Upcoming Conference Participation

    SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor conferences: UBS Global Healthcare Conference on Thursday, November 14, 2024 at 11:45am Eastern Time (8:45am Pacific Time), Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024 at 11:30am Eastern Time (8:30am Pacific Time), Jefferies London Healthcare
  • Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024

    SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2024 results after the financial markets close on Wednesday, November 6, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2024 financial and operating results. A live webcast of the call will be
  • Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union

    SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company’s Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the European Union (EU). “High satisfaction and quality of life benefits were recently shown in a clinical study using
Read more news

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Frequently Asked Questions Regarding Tandem Diabetes Care

Where is Tandem Diabetes Care located?
Tandem Diabetes Care's headquarters are located at 12400 High Bluff Dr, San Diego, California, 92130, United States
What is Tandem Diabetes Care's phone number?
Tandem Diabetes Care's phone number is (858) 366-6900
What is Tandem Diabetes Care's stock symbol?
Tandem Diabetes Care's stock symbol is TNDM
What is Tandem Diabetes Care's official website?
Tandem Diabetes Care's official website is www.tandemdiabetes.com
What is Tandem Diabetes Care's Revenue?
Tandem Diabetes Care's revenue is $770 Million
What is Tandem Diabetes Care's SIC code?
Tandem Diabetes Care's SIC: 38,384
What is Tandem Diabetes Care's NAICS code?
Tandem Diabetes Care's NAICS: 33,339
How many employees does Tandem Diabetes Care have?
Tandem Diabetes Care has 2,400 employees
What industry does Tandem Diabetes Care belong to?
Tandem Diabetes Care is in the industry of: Medical Devices & Equipment, Manufacturing
What is Tandem Diabetes Care competition?
Tandem Diabetes Care top competitors include: Insulet, Applied Medical, Hollister, ABIOMED
What companies has Tandem Diabetes Care acquired?
Tandem Diabetes Care has acquired the companies: AMF Medical, Sugarmate, Capillary Biomedical
What technology does Tandem Diabetes Care use?
Some of the popular technologies that Tandem Diabetes Care uses are: Solidworks, Qualtrics Site Intercept, Microsoft IIS, Angular 4
Who is the CFO of Tandem Diabetes Care?
Tandem Diabetes Care's CFO is Leigh Vosseller
How do I contact Tandem Diabetes Care?
Tandem Diabetes Care contact info: Phone number: (858) 366-6900 Website: www.tandemdiabetes.com
What does Tandem Diabetes Care do?

Founded in 2006 and headquartered in San Diego, California, Tandem Diabetes Care is a company that manufactures medical devices that help measure blood sugar in the blood of diabetic patients.... Read More

What are Tandem Diabetes Care social media links?
Tandem Diabetes Care Linkedin page Tandem Diabetes Care Twitter page Tandem Diabetes Care Facebook page
How much funding has Tandem Diabetes Care raised to date?
Tandem Diabetes Care has raised $884.8 Million in 13 funding rounds
When was the last funding round for Tandem Diabetes Care?
Tandem Diabetes Care closed its last funding round on May 13, 2020 with the amount of $250 Million
Who invested in Tandem Diabetes Care?
Tandem Diabetes Care has 21 investors including Delphi Ventures, Second Technology Capital Investors, Domain Partners and TPG Biotechnology Partners.
Is Tandem Diabetes Care a public company?
Yes, Tandem Diabetes Care is a public company and is traded under the symbol TNDM
See more information about Tandem Diabetes Care

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.